HomeNewsBusinessRecent incidents isolated, says SpiceJet amid DGCA show cause notice

Recent incidents isolated, says SpiceJet amid DGCA show cause notice

The DGCA found that SpiceJet failed to establish a safe, efficient and reliable air service.

July 06, 2022 / 16:45 IST
Story continues below Advertisement
SpiceJet flight | Representative image
SpiceJet flight | Representative image

Budget airline SpiceJet on July 6 said that the most recent incidents of emergency landings of its aircraft are isolated in nature and that its initial investigation shows that there isn't a specific maintenance issue within its fleet, the airline told CNBC TV-18.

The statement by the airline comes after India's aviation regulator Directorate General of Civil Aviation (DGCA) issued a show-cause notice to the airline over ‘poor safety oversight’.

Story continues below Advertisement

The DGCA found that SpiceJet has failed to establish a safe, efficient and reliable air service. The regulator has been called upon by the accountable manager of SpiceJet to show cause within three weeks as to why action should not be taken against the airline.

SpiceJet also told CNBC TV-18 that investigations are being carried out as per norms into the recent grounding of its aircraft.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show